Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Queensland Health
Boehringer Ingelheim
Johnson and Johnson
AstraZeneca
Deloitte
US Army
Dow
Fuji
Citi

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089351

« Back to Dashboard

NDA 089351 describes ROXICET, which is a drug marketed by West-ward Pharms Int and Roxane and is included in three NDAs. It is available from one supplier. Additional details are available on the ROXICET profile page.

The generic ingredient in ROXICET is acetaminophen; oxycodone hydrochloride. There are sixty-six drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride profile page.
Summary for 089351
Tradename:ROXICET
Applicant:West-ward Pharms Int
Ingredient:acetaminophen; oxycodone hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 089351
Mechanism of ActionFull Opioid Agonists

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;ORALStrength325MG/5ML;5MG/5ML
Approval Date:Dec 3, 1986TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Federal Trade Commission
Cantor Fitzgerald
Moodys
Chubb
Teva
US Department of Justice
Medtronic
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot